Literature DB >> 7568370

Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts.

L Teusch1, N Scherbaum, H Böhme, S Bender, G Eschmann-Mehl, M Gastpar.   

Abstract

Little is known about sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. In the present study schizophrenic patients (n = 45, mostly under neuroleptic treatment), neurotic patients (n = 50, mostly treated without medication), methadone-substituted opiate addicts (n = 37), and normal controls (n = 41) were included. They were interviewed with the aid of a sex-differentiated semistructured questionnaire on sexual function. All the methadone-substituted opiate addicts and nearly all the schizophrenic patients suffered from dysfunctions in at least one criterion. The three clinical groups differed significantly from the controls in sexual interest, emotional arousal, physiological arousal (erectile function/vaginal lubrication), performance (ejaculatory function/vaginism, dyspareunia), and orgasm satisfaction. Characteristic patterns of dysfunction were found in the male patients. The schizophrenic patients had significantly more dysfunctions of interest, physiological arousal, performance, and orgasm than the controls. Emotional arousal, erectile and ejaculatory functions, and orgasm satisfaction were impaired more frequently in the male schizophrenics than in the neurotic patients. Reduced sexual interest, emotional arousal, and orgasm satisfaction were reported more frequently by the methadone-substituted opiate addicts than by the neurotic men. Emotional arousal was even more frequently reduced than in the schizophrenic men. There was no correlation between sexual dysfunction and particular neuroleptics or neuroleptic or methadone dosage. The results are compared with the literature and suggestions made for further investigations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568370     DOI: 10.1055/s-2007-979596

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  14 in total

1.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

2.  HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.

Authors:  Christina S Meade; Roger D Weiss; Garrett M Fitzmaurice; Sabrina A Poole; Geetha A Subramaniam; Ashwin A Patkar; Hilary S Connery; George E Woody
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

Review 3.  Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors:  A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

4.  Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey.

Authors:  Ellen Wan-Yuk Harley; Jed Boardman; Tom Craig
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-08-23       Impact factor: 4.328

5.  Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications.

Authors:  Aina Kikelomo Oyekanmi; Adegoke Oloruntoba Adelufosi; Olukayode Abayomi; Timothy Olaolu Adebowale
Journal:  BMC Res Notes       Date:  2012-06-07

Review 6.  Sexual dysfunction in patients with alcohol and opioid dependence.

Authors:  Sandeep Grover; Surendra K Mattoo; Shreyas Pendharkar; Venkatesh Kandappan
Journal:  Indian J Psychol Med       Date:  2014-10

7.  A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.

Authors:  Anil Kumar M Nagaraj; Nagesh B Pai; Satheesh Rao
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

8.  Trazodone in methandone induced erectile dysfunction.

Authors:  Faezeh Tatari; Vahid Farnia; Reza Faghih Nasiri; Farid Najafi
Journal:  Iran J Psychiatry       Date:  2010

9.  Impact of morphine dependency and detoxification by methadone on male's rat reproductive system.

Authors:  Mahnaz Ghowsi; Namdar Yousofvand
Journal:  Iran J Reprod Med       Date:  2015-05

10.  When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.

Authors:  Jens Reimer; Eduard Boniakowski; Christian Bachner; Bernd Weber; Wieland Tietje; Uwe Verthein; Stephan Walcher
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.